Skip to main content
Log in

Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

The presence of apical pouches in hypertrophic cardiomyopathy (HCM) may portend poor prognosis. We sought to study if the use cardiac magnetic resonance imaging (CMR) improves the detection of apical pouches in HCM compared to echocardiography. A retrospective review was performed of all consecutive HCM patients with an apical pouch identified by CMR at Mayo Clinic from May 2004 to Sept 2011. Clinical data was abstracted and CMR and echocardiographic images were analyzed. There were 56 consecutive HCM patients with an apical pouch identified by CMR. The predominant morphological type was apical in 41 (73.2 %), followed by sigmoid in 6 (10.7 %), reversed curve in 6 (10.7 %) and neutral in 3 (5.4 %). Obstructive physiology or systolic anterior motion of the mitral valve leaflet was evident in 23 (41.1 %). Late gadolinium enhancement was present in 47 (87.0 %) patients. Apical pouches were detected in only 18 (32.1 %) patients on echocardiography. Even when intravenous contrast was used (29/56 patients), in 16/29 (55.2 %) pouches were missed on echocardiography. Pouch length and neck dimensions in systole and diastole, measured on CMR, were larger among those patients in whom pouches were detected on echocardiography suggesting only larger pouches can be identified on echocardiography. In the largest CMR series to date of apical pouches in HCM, we show that while apical pouches are most commonly seen in apical HCM, they can be found in other phenotypic variants. CMR is better suited for the evaluation of apical pouches compared to echocardiography even with the use of intravenous contrast. CMR is likely a better tool for evaluating the cardiac apical structures including apical pouches when clinically indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

HCM:

Hypertrophic cardiomyopathy

LV:

Left ventricle

SCD:

Sudden cardiac death

ICD:

Implantable cardioverter-defibrillator

CMR:

Cardiac magnetic resonance

NSVT:

Non-sustained ventricular tachycardia

LVOT:

Left ventricular outflow tract

SAM:

Systolic anterior motion

SSFP:

Steady state free precession

LGE:

Late gadolinium enhancement

References

  1. Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26(7):1699–1708

    Article  CAS  PubMed  Google Scholar 

  2. Binder J et al (2006) Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clinic Proc 81(4):459–467

    Article  Google Scholar 

  3. Maron MS et al (2008) Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118(15):1541–1549

    Article  PubMed  Google Scholar 

  4. Ando H et al (1990) Apical segmental dysfunction in hypertrophic cardiomyopathy: subgroup with unique clinical features. J Am Coll Cardiol 16(7):1579–1588

    Article  CAS  PubMed  Google Scholar 

  5. Wigle ED, Rakowski H (1992) Hypertrophic cardiomyopathy: when do you diagnose midventricular obstruction versus apical cavity obliteration with a small nonobliterated area at the apex of the left ventricle? J Am Coll Cardiol 19(3):525–526

    Article  CAS  PubMed  Google Scholar 

  6. Nakamura T et al (1992) Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 19(3):516–524

    Article  CAS  PubMed  Google Scholar 

  7. Fighali S et al (1987) Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 9(2):288–294

    Article  CAS  PubMed  Google Scholar 

  8. Matsubara K et al (2003) Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42(2):288–295

    Article  PubMed  Google Scholar 

  9. Sanghvi NK, Tracy CM (2007) Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm. Pacing Clin Electrophysiol PACE 30(6):799–803

    Article  Google Scholar 

  10. Tse HF, Ho HH (2003) Sudden cardiac death caused by hypertrophic cardiomyopathy associated with midventricular obstruction and apical aneurysm. Heart 89(2):178

    Article  PubMed Central  PubMed  Google Scholar 

  11. Lazaros G et al (2007) Apical hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm. Int J Cardiol 114(2):E45–E47

    Article  PubMed  Google Scholar 

  12. Gersh BJ et al (2011) ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124(24):2761–2796

    Article  PubMed  Google Scholar 

  13. Binder J et al (2011) Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr 24(7):775–781

    Article  PubMed  Google Scholar 

  14. Moon JC et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90(6):645–649

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Rickers C et al (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112(6):855–861

    Article  PubMed  Google Scholar 

  16. Maron MS, Lesser JR, Maron BJ (2010) Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. Am J Cardiol 105(12):1842–1843

    Article  PubMed  Google Scholar 

  17. Kim KH et al (2012) Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with “pure” apical hypertrophic cardiomyopathy. J cardiovasc Magn Reson 14:52

    Article  PubMed Central  PubMed  Google Scholar 

  18. Fattori R et al (2010) Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Am J Cardiol 105(11):1592–1596

    Article  PubMed  Google Scholar 

  19. McKenna W et al (1981) Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 47(3):532–538

    Article  CAS  PubMed  Google Scholar 

  20. Elliott P et al (2006) Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy. Eur Heart J 27(24):3073 author reply 3073-4

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kalie Y. Kebed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kebed, K.Y., Al Adham, R.I., Bishu, K. et al. Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI. Int J Cardiovasc Imaging 30, 591–597 (2014). https://doi.org/10.1007/s10554-013-0355-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-013-0355-y

Keywords

Navigation